Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Wave Life Sci Ord Sh
(NQ:
WVE
)
5.340
-0.340 (-5.99%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Wave Life Sci Ord Sh
< Previous
1
2
3
4
5
6
Next >
Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
September 20, 2024
Wave Life Sciences has received recent Wall Street price targets forecasting big upside. The company has a potentially "industry-leading" treatment.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
August 14, 2024
William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst rates the stock Outperform, noting its potential in treating alpha-1...
Via
Benzinga
Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
August 12, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (4 Ratings)
August 09, 2024
Via
Benzinga
WVE Stock Earnings: WAVE Life Sciences Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
WVE stock results show that WAVE Life Sciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
What Analysts Are Saying About WAVE Life Sciences Stock
June 26, 2024
Via
Benzinga
WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
May 15, 2024
Via
Benzinga
Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
August 01, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 26, 2024
Via
Benzinga
What's Going On With Wave Life Sciences Stock On Tuesday?
June 25, 2024
Wave Life Sciences reports Phase 1b/2a SELECT-HD trial results for WVE-003 in Huntington's disease, demonstrates promise as a disease-modifying therapy.
Via
Benzinga
Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
June 25, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
June 12, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference
May 30, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
WVE Stock Earnings: WAVE Life Sciences Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
WVE stock results show that WAVE Life Sciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
May 09, 2024
Appointment builds on Wave’s recent progress advancing innovative genetic targets, such as INHBE, and continues to add significant experience to accelerate the rapid identification and translation of...
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
May 02, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
April 30, 2024
Proof-of-mechanism data for WVE-006 in individuals with AATD remain on track for 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing
April 23, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
April 04, 2024
Via
Benzinga
Wave Life Sciences to Present at Upcoming Investor Conferences
March 27, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
March 07, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 07, 2024
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via
Benzinga
WVE Stock Earnings: WAVE Life Sciences Beats EPS, Beats Revenue for Q4 2023
March 06, 2024
WVE stock results show that WAVE Life Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
March 06, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
Via
Benzinga
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 06, 2024
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 6, 2024
March 06, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.